Page 63 - GTM-1-1

Global Translational Medicine Fusion events identified in tumor

WHO classification of tumours of the central nervous https://doi.org/10.1038/nrg2883
system. Acta Neuropathol, 114(2): 97–109.
18. Hakim O, Resch W, Yamane A, et al., 2012, DNA damage
https://doi.org/10.1007/s00401-007-0243-4 defines sites of recurrent chromosomal translocations in B
lymphocytes. Nature, 484(7392): 69–74.
7. Louis DN, Perry A, Reifenberger G, et al., 2016, The 2016
World Health Organization classification of tumors of the https://doi.org/10.1038/nature10909
central nervous system: A summary. Acta Neuropathol, 19. Zhang Y, McCord RP, Ho YJ, et al., 2012, Spatial organization
131(6): 803–820.
of the mouse genome and its role in recurrent chromosomal
https://doi.org/10.1007/s00401-016-1545-1 translocations. Cell, 148(5): 908–921.
8. Stupp R, Mason WP, van den Bent MJ, et al., 2005, https://doi.org/10.1016/j.cell.2012.02.002
Radiotherapy plus concomitant and adjuvant temozolomide 20. Nowell PC, 1962, The minute chromosome (Phl) in chronic
for glioblastoma. N Engl J Med, 352(10): 987–996.
granulocytic leukemia. Blut, 8: 65–66.
https://doi.org/10.1097/01.cot.0000289242.47980.f9
https://doi.org/10.1007/bf01630378
9. Agarwala SS, Kirkwood JM, 2000, Temozolomide, a 21. Caspersson T, Zech L, Johansson C, 1970, Differential binding
novel alkylating agent with activity in the central nervous of alkylating fluorochromes in human chromosomes. Exp
system, may improve the treatment of advanced metastatic Cell Res, 60(3): 315–319.
melanoma. Oncologist, 5(2): 144–151.
https://doi.org/10.1016/0014-4827(70)90523-9
https://doi.org/10.1634/theoncologist.5-2-144
22. Rowley JD, 1973, Letter: A new consistent chromosomal
10. National Comprehensive Cancer Network, 2019, CNS abnormality in chronic myelogenous leukaemia identified
Cancers (Version1. 2019). National Comprehensive Cancer by quinacrine fluorescence and Giemsa staining. Nature,
Network.
243(5405): 290–293.
11. Jiang T, Mao Y, Ma W, et al., 2016, CGCG clinical practice https://doi.org/10.1038/243290a0
guidelines for the management of adult diffuse gliomas.
Cancer Lett, 375(2): 263–273. 23. Miyoshi I, Hiraki S, Kimura I, et al., 1979, 2/8 translocation
in a Japanese Burkitt’s lymphoma. Experientia, 35(6):
12. Mertens F, Johansson B, Fioretos T, et al., 2015, The emerging 742–743.
complexity of gene fusions in cancer. Nat Rev Cancer, 15(6):
371–381. https://doi.org/10.1007/bf01968217
https://doi.org/10.1038/nrc3947 24. Rowley JD, Golomb HM, Dougherty C, 1977, 15/17
translocation, a consistent chromosomal change in acute
13. Singh D, Chan JM, Zoppoli P, et al., 2012, Transforming promyelocytic leukaemia. Lancet, 1(8010): 549–550.
fusions of FGFR and TACC genes in human glioblastoma.
Science, 337(6099): 1231–1235. https://doi.org/10.1016/s0140-6736(77)91415-5
https://doi.org/10.1126/science.1220834 25. Wachtel M, Dettling M, Koscielniak E, et al., 200, Gene
expression signatures identify rhabdomyosarcoma subtypes
14. Bandopadhayay P, Ramkissoon LA, Jain P, et al., 2016, and detect a novel t(2;2)(q35;p23) translocation fusing
MYB-QKI rearrangements in angiocentric glioma drive PAX3 to NCOA1. Cancer Res, 64(16): 5539–5545.
tumorigenicity through a tripartite mechanism. Nat Genet,
48(3): 273–282. https://doi.org/10.1158/0008-5472.can-04-0844
https://doi.org/10.1158/1538-7445.am2016-4372 26. Sinclair PB, Nacheva EP, Leversha M, et al., 2000, Large
deletions at the t(9;22) breakpoint are common and may
15. Bao ZS, Chen HM, Yang MY, et al., 201, RNA-seq of 272 identify a poor-prognosis subgroup of patients with chronic
gliomas revealed a novel, recurrent PTPRZ1-MET fusion myeloid leukemia. Blood, 95(3): 738–743.
transcript in secondary glioblastomas. Genome Res, 24(11):
1765–1773. https://doi.org/10.1182/blood.v95.3.738.003k21_738_743
https://doi.org/10.1101/gr.165126.113 27. Soda M, Choi YL, Enomoto M, et al., 2007, Identification of
the transforming EML4-ALK fusion gene in non-small-cell
16. Mitelman F, Johansson B, Mertens F, 200, Fusion genes lung cancer. Nature, 448(7153): 561–566.
and rearranged genes as a linear function of chromosome
aberrations in cancer. Nat Genet, 36(4): 331–334. https://doi.org/10.1038/nature05945
https://doi.org/10.1038/ng1335 28. Eck MJ, Manley PW, 2009, The interplay of structural
information and functional studies in kinase drug design:
17. Mani RS, Chinnaiyan AM, 2010, Triggers for genomic Insights from BCR-Abl. Curr Opin Cell Biol, 21(2): 288–295.
rearrangements: insights into genomic, cellular and
environmental influences. Nat Rev Genet, 11(12): 819–829. https://doi.org/10.1016/j.ceb.2009.01.014

Volume 1 Issue 1 (2022) 8 https://doi.org/10.36922/gtm.v1i1.54